Efficacy and Safety of Pharmacist-Managed NSAIDs Deprescribing: A Jordanian Outpatient Study

Table 2

Chronic disease among participants, number of medications used, and groups of medications used (N = 100).

Variables	N (%)
None	45 (45)
Hypertension	21 (21)
Cardiovascular/dyslipidemia	2 (2)
GI diseases	20 (20)
Psychiatry disorders	1 (1)
Respiratory disorders	11 (11)
Number of medications
None	7 (7)
1–3 medications	91 (91)
More than 4	2 (2)
Group of medications
Analgesic	84 (84)
Antihypertensives	21 (21)
Bronchodilator	8 (8)

Psychiatry disorders were depression and anxiety. Respiratory disorders were asthma and COPD.